Rivaroxaban Kit
NDC 62332-240
Product Information
Rivaroxaban is a ANDA-approved product labeled by Alembic Pharmaceuticals Inc.. Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. It is supplied as a kit. This product entry covers the primary NDC 62332-240 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
RIVAROXABAN (NDC 62332-231): BROWN (C48332)
RIVAROXABAN (NDC 62332-231): TRIANGLE (C48353)
RIVAROXABAN (NDC 62332-231): 7 MM
504 RIVAROXABAN (NDC 62332-231):
505 RIVAROXABAN (NDC 62332-231): 1
Code Structure Chart
Product Details
What is NDC 62332-240?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- RIVAROXABAN (NDC 62332-230)
- RIVAROXABAN (UNII: 9NDF7JZ4M3)
- RIVAROXABAN (UNII: 9NDF7JZ4M3) (Active Moiety)
- RIVAROXABAN (NDC 62332-231)
- RIVAROXABAN (UNII: 9NDF7JZ4M3)
- RIVAROXABAN (UNII: 9NDF7JZ4M3) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- RIVAROXABAN (NDC 62332-230)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- POLYETHYLENE GLYCOL 8000 (UNII: Q662QK8M3B)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- RIVAROXABAN (NDC 62332-231)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- POLYETHYLENE GLYCOL 8000 (UNII: Q662QK8M3B)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1114198 - rivaroxaban 10 MG Oral Tablet
- RxCUI: 1232082 - rivaroxaban 15 MG Oral Tablet
- RxCUI: 1232086 - rivaroxaban 20 MG Oral Tablet
- RxCUI: 1549682 - {42 (rivaroxaban 15 MG Oral Tablet) / 9 (rivaroxaban 20 MG Oral Tablet) } Pack
- RxCUI: 1549682 - rivaroxaban 30-Day Starter Pack (42-15 MG Oral Tablets & 9-20 MG Oral Tablets)
* Please review the full disclaimer at the bottom of this page.